These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 20392463

  • 21. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
    Prochorec-Sobieszek M, Bilińska ZT, Grzybowski J, Mazurkiewicz L, Skwarek M, Walczak E, Michalak E, Cedro K, Chmielak Z, Debski A, Demkow M, Witkowski A, Wagner T, Ruzyłło W.
    Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
    [Abstract] [Full Text] [Related]

  • 22. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T, Blasi F, Talarico D.
    Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
    [Abstract] [Full Text] [Related]

  • 23. Downregulated expression of plasminogen activator inhibitor-1 augments myocardial neovascularization and reduces cardiomyocyte apoptosis after acute myocardial infarction.
    Xiang G, Schuster MD, Seki T, Witkowski P, Eshghi S, Itescu S.
    J Am Coll Cardiol; 2005 Aug 02; 46(3):536-41. PubMed ID: 16053971
    [Abstract] [Full Text] [Related]

  • 24. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
    Fibbi G, D'Alessio S, Pucci M, Cerletti M, Del Rosso M.
    Biol Chem; 2002 Jan 02; 383(1):127-36. PubMed ID: 11928807
    [Abstract] [Full Text] [Related]

  • 25. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
    Nowakowska A.
    Ann Acad Med Stetin; 2005 Jan 02; 51(1):95-105. PubMed ID: 16496609
    [Abstract] [Full Text] [Related]

  • 26. Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor-1.
    Stevens PT, Kicic A, Sutanto EN, Knight DA, Stick SM.
    Clin Exp Allergy; 2008 Dec 02; 38(12):1901-10. PubMed ID: 19037965
    [Abstract] [Full Text] [Related]

  • 27. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M, Vaheri A, Virolainen S, Saarialho-Kere U, Jahkola T, Sirén V.
    Br J Dermatol; 2004 Dec 02; 151(6):1189-96. PubMed ID: 15606514
    [Abstract] [Full Text] [Related]

  • 28. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
    Warnecke-Eberz U, Prenzel KL, Baldus SE, Metzger R, Dienes HP, Bollschweiler E, Hoelscher AH, Schneider PM.
    Pancreas; 2008 Mar 02; 36(2):173-7. PubMed ID: 18376309
    [Abstract] [Full Text] [Related]

  • 29. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy.
    Tentolouris C, Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Trikas A, Toutouzas P, Stefanadis C.
    Int J Cardiol; 2004 Apr 02; 94(2-3):301-5. PubMed ID: 15093997
    [Abstract] [Full Text] [Related]

  • 30. Immunohistochemical study of remodeling of myocardial lymphatic and blood microvascular structures in terminal heart failure: differences between ischemic and dilated cardiomyopathy.
    Dashkevich A, Bloch W, Antonyan A, Goebel H, Fries JU, Schlensak C, Beyersdorf F, Geissler HJ.
    Lymphology; 2010 Sep 02; 43(3):110-7. PubMed ID: 21226413
    [Abstract] [Full Text] [Related]

  • 31. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation.
    Parodi O, De Maria R, Oltrona L, Testa R, Sambuceti G, Roghi A, Merli M, Belingheri L, Accinni R, Spinelli F.
    Circulation; 1993 Aug 02; 88(2):509-22. PubMed ID: 8339413
    [Abstract] [Full Text] [Related]

  • 32. Endothelin and von Willebrand factor as parameters of endothelial function in idiopathic dilated cardiomyopathy: different stimuli for release before and after heart transplantation?
    Galatius S, Wroblewski H, Sørensen VB, Bie P, Parving HH, Kastrup J.
    Am Heart J; 1999 Mar 02; 137(3):549-54. PubMed ID: 10047640
    [Abstract] [Full Text] [Related]

  • 33. New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy.
    Roura S, Gálvez-Montón C, Pujal JM, Casani L, Fernández MA, Astier L, Gastelurrutia P, Domingo M, Prat-Vidal C, Soler-Botija C, Llucià-Valldeperas A, Llorente-Cortés V, Bayes-Genis A.
    Atherosclerosis; 2013 Oct 02; 230(2):354-64. PubMed ID: 24075768
    [Abstract] [Full Text] [Related]

  • 34. Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
    Sartori TM, Maurizio PG, Sara P, Ugolino L, Annalisa A, Panagiotis T, Massimo F, Antonio G.
    J Heart Lung Transplant; 1999 Jul 02; 18(7):693-700. PubMed ID: 10452346
    [Abstract] [Full Text] [Related]

  • 35. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation.
    Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, Llach A, Hove-Madsen L, Pons Lladó G, Farré J, Cinca J, Bayes-Genis A.
    Eur J Heart Fail; 2007 Oct 02; 9(10):995-1002. PubMed ID: 17719840
    [Abstract] [Full Text] [Related]

  • 36. Post-transcriptional modifications of VEGF-A mRNA in non-ischemic dilated cardiomyopathy.
    Kowalczyk J, Domal-Kwiatkowska D, Mazurek U, Zembala M, Michalski B, Zembala M.
    Cell Mol Biol Lett; 2007 Sep 02; 12(3):331-47. PubMed ID: 17297559
    [Abstract] [Full Text] [Related]

  • 37. Impact of cardiac transplantation on molecular pathology of ET-1, VEGF-C, and mitochondrial metabolism and morphology in dilated versus ischemic cardiomyopathic patients.
    Aharinejad S, Schäfer R, Hofbauer R, Abraham D, Blumer R, Miksovsky A, Traxler H, Pullirsch D, Alexandrowicz R, Taghavi S, Kocher A, Laufer G.
    Transplantation; 2001 Sep 27; 72(6):1043-9. PubMed ID: 11579298
    [Abstract] [Full Text] [Related]

  • 38. Cellular autotransplantation for ischemic and idiopathic dilated cardiomyopathy. Preliminary report.
    Argüero R, Careaga-Reyna G, Castaño-Guerra R, Garrido-Garduño MH, Magaña-Serrano JA, de Jesús Nambo-Lucio M.
    Arch Med Res; 2006 Nov 27; 37(8):1010-4. PubMed ID: 17045119
    [Abstract] [Full Text] [Related]

  • 39. Endomyocardial HLA expression is increased to the same extent in idiopathic and secondary dilated cardiomyopathy.
    Klappacher G, Mehrabi M, Franzen P, Plesch K, Binder M, Haab D, Urban S, Laufer G, Glogar HD, Eichler HG.
    Immunol Lett; 1994 Jun 27; 41(1):59-66. PubMed ID: 7959904
    [Abstract] [Full Text] [Related]

  • 40. [Surgical treatment for ischemic cardiomyopathy].
    Sawa Y.
    Kyobu Geka; 2011 Oct 27; 64(11):1014-21. PubMed ID: 22111347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.